Sagility Ltd Q2FY26 Concall Decoded: AI is the New BPO Intern, and It Doesn’t Need Coffee Breaks ☕🤖
Opening Hook When your client asks for “cost savings,” and you hand them a GenAI bot that never sleeps—that’s Sagility’s vibe this quarter. While the US healthcare industry drowns in tariffs, reforms, and paperwork thicker than a Bollywood script, Sagility’s management turned it into a 25% growth story. Ramesh Gopalan & team basically said: “AI is eating our margins? Fine, we’ll eat more contracts.” Keep reading—because when CFOs start talking in constant currency and end with “25% EBITDA,” you know the spreadsheets have gone nuclear.
At a Glance
Revenue ₹1,658.5 Cr – Up 25% YoY; CFO insists it’s “real” and not Excel magic.
EBITDA ₹435.2 Cr (26.2%) – GenAI officially earns its badge as cost assassin.
PAT ₹301 Cr – Up 84%; someone’s finally enjoying forex gains.
H1 Revenue ₹3,197 Cr – Up 25.5%; even the rupee couldn’t dull the shine.
Interim Dividend ₹0.05/share – Barely a samosa, but hey, it’s a start.
Employee Count 44,185 – The “AI won’t take jobs” crowd quietly sweating.
Management’s Key Commentary
Ramesh Gopalan: “We delivered 25% growth and 26% margins—proof that GenAI works.” (Translation: Machines now officially outperform middle management. 😏)
Ramesh: “Payer segment grew 24%, provider 33%. Healthcare chaos = more contracts.” (Hospitals panic, Sagility profits. Circle of life.)
Ramesh: “We’ve deployed 25 AI use cases across nine clients.” (AI interns now outnumber human ones, and they don’t unionize.)
CFO Srini: “DSO at 78 days, among the best in the industry.” (Translation: We actually get paid on time—miracle!)
Ramesh: “We expect constant currency growth of 21%+ for FY26.” (In normal English: We’re done being humble.)
Ramesh: “AI may cannibalize revenue, but we’ll just sell more AI.” (The capitalist ouroboros: eat your own tail, bill the client.)
Srini: “ROCE stable at 50%, free cash flow ₹478 Cr.” (Accountants everywhere just nodded approvingly.)
